The Food and Drug Administration commissioner's effort to drastically shorten the review of drugs favored by President Donald ...

The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's new fast-track ...

A new study co-written by a University of Illinois Urbana-Champaign expert in operations management finds that drugs approved ...

The FDA granted Priority Review to the supplemental New Drug Application (sNDA) for lurbinectedin in combination with atezolizumab as a first-line maintenance treatment for patients with ...

The firm said at the JP Morgan Healthcare Conference that it wants zorevunersen to be approved as a disease-modifying ...

FDA staffers and outside experts worry the program runs afoul of legal, ethical and scientific standards used to review new ...